Article content

Health Canada has issued a recall for two lots of APO-Mometasone nasal spray over a possible bacterial contamination.

The product in question — used to treat allergy symptoms, sinusitis and nasal polyps — is “mometasone furoate aqueous nasal spray” or “50 mcg/metered spray” with expiry dates in September or October 2025.

Article content

Apotex Inc. recalled the items over possible contamination with Burkholderia cepacia complex, a group of bacteria Health Canada described as posing minimal risk to healthy people.

“However, children, those with chronic lung diseases, people who are pregnant, seniors and those with a weakened immune system may be at a higher risk of illness,” the agency said.

It added that the effects of the bacteria can range from no symptoms at all to serious infections.

“In severe cases, Bcc can lead to bloodstream infections that may result in sepsis … and death,” Health Canada said. “Bcc is often resistant to common antibiotics. People experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure, should seek medical attention.”

The agency suggested those with a recalled product return it to a local pharmacy for disposal.

Share this article in your social network